Subscribe to RSS
Potential Role of Growth Hormone in a Pediatric Transient Ischemic Attack
Growth hormone (GH) is often prescribed in pediatric populations with short stature and is associated with several potential adverse events. One underrecognized potential adverse event is its effect on intracerebral vasculature, with concern for its ability to cause cerebrovascular accident. We present a pediatric case of presumed transient ischemic attack in the setting of chronic GH administration for idiopathic short stature syndrome. We propose potential pathogenic mechanisms for intracerebral vessel stenosis. We hope this case becomes a resource for clinicians and other healthcare providers when deciding whether or not to start GH in their young patients.
Expressed and written consent was obtained by the patient's legal guardian, though no identifying information has been used.
Received: 04 May 2020
Accepted: 24 June 2020
05 August 2020 (online)
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Adil MM, Qureshi AI, Beslow LA, Jordan LC. Transient ischemic attack requiring hospitalization of children in the United States: kids' inpatient database 2003 to 2009. Stroke 2014; 45 (03) 887-888
- 2 Surmava AM, Maclagan LC, Khan F, Kapral MK, Hall RE, deVeber G. Incidence and current treatment gaps in pediatric stroke and TIA: an Ontario-wide population-based study. Neuroepidemiology 2019; 52 (3-4): 119-127
- 3 Poidvin A, Touzé E, Ecosse E. et al. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood. Neurology 2014; 83 (09) 780-786
- 4 Child CJ, Zimmermann AG, Chrousos GP. et al. Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program. J Clin Endocrinol Metab 2019; 104 (02) 379-389
- 5 Mosca S, Paolillo S, Colao A. et al. Cardiovascular involvement in patients affected by acromegaly: an appraisal. Int J Cardiol 2013; 167 (05) 1712-1718
- 6 Rizzoni D, Porteri E, Giustina A. et al. Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension 2004; 43 (03) 561-565
- 7 Brevetti G, Marzullo P, Silvestro A. et al. Early vascular alterations in acromegaly. J Clin Endocrinol Metab 2002; 87 (07) 3174-3179